75 related articles for article (PubMed ID: 23875248)
1. A clinical study on insomnia in patients with cancer during chemotherapy containing high-dose glucocorticoids.
Zhao J; Dai YH; Xi QS; Yu SY
Pharmazie; 2013 Jun; 68(6):421-7. PubMed ID: 23875248
[TBL] [Abstract][Full Text] [Related]
2. A multinational study of sleep disorders during female mid-life.
Blümel JE; Cano A; Mezones-Holguín E; Barón G; Bencosme A; Benítez Z; Bravo LM; Calle A; Flores D; Espinoza MT; Gómez G; Hernández-Bueno JA; Laribezcoa F; Martino M; Lima S; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Sánchez H; Tserotas K; Vallejo MS; Witis S; Zúñiga MC; Chedraui P
Maturitas; 2012 Aug; 72(4):359-66. PubMed ID: 22717489
[TBL] [Abstract][Full Text] [Related]
3. Main neuroendocrine features and therapy in primary sleep troubles.
Amihăesei IC; Mungiu OC
Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543
[TBL] [Abstract][Full Text] [Related]
4. [The effectiveness of treatment with trazodone in patients with primary insomnia without and with prior history of hypnotics use].
Wichniak A; Wierzbicka A; Sobańska A; Szatkowska E; Czasak K; Musińska I; Jernajczyk W
Pol Merkur Lekarski; 2007 Jul; 23(133):41-6. PubMed ID: 18051828
[TBL] [Abstract][Full Text] [Related]
5. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
Dorsey CM; Lee KA; Scharf MB
Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
[TBL] [Abstract][Full Text] [Related]
6. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
Walsh JK; Salkeld L; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2010 Jan; 11(1):23-30. PubMed ID: 19945340
[TBL] [Abstract][Full Text] [Related]
7. Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo.
Ozone M; Yagi T; Itoh H; Tamura Y; Inoue Y; Uchimura N; Sasaki M; Shimizu T; Terzano MG; Parrino L
Pharmacopsychiatry; 2008 May; 41(3):106-14. PubMed ID: 18484552
[TBL] [Abstract][Full Text] [Related]
8. A WASO sub-group analysis of a 6-month study of eszopiclone 3 mg.
Krystal AD; Huang H; Zummo J; Grinnell T; Marshall RD
Sleep Med; 2012 Jun; 13(6):691-6. PubMed ID: 22465450
[TBL] [Abstract][Full Text] [Related]
9. [Observation on the therapeutic effect of neck clustered needling on insomnia].
Qi LZ; Ma XP; Yang L
Zhongguo Zhen Jiu; 2008 Dec; 28(12):861-4. PubMed ID: 19127908
[TBL] [Abstract][Full Text] [Related]
10. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
11. Effects of insomnia and sleep medication on health-related quality of life.
Sasai T; Inoue Y; Komada Y; Nomura T; Matsuura M; Matsushima E
Sleep Med; 2010 May; 11(5):452-7. PubMed ID: 20381419
[TBL] [Abstract][Full Text] [Related]
12. [Effects of midazolam and estazolam as hypnotics in hypertensive patients with chronic insomnia: a multicentre, open labeled, randomized clinical trial].
Wang XL; Ke YN;
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):338-40. PubMed ID: 16776928
[TBL] [Abstract][Full Text] [Related]
13. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
Riemann D; Voderholzer U; Cohrs S; Rodenbeck A; Hajak G; Rüther E; Wiegand MH; Laakmann G; Baghai T; Fischer W; Hoffmann M; Hohagen F; Mayer G; Berger M
Pharmacopsychiatry; 2002 Sep; 35(5):165-74. PubMed ID: 12237787
[TBL] [Abstract][Full Text] [Related]
14. Treatment effects of gabapentin for primary insomnia.
Lo HS; Yang CM; Lo HG; Lee CY; Ting H; Tzang BS
Clin Neuropharmacol; 2010; 33(2):84-90. PubMed ID: 20124884
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients.
Mendels J
J Clin Psychiatry; 1994 Feb; 55(2):60-5. PubMed ID: 7915708
[TBL] [Abstract][Full Text] [Related]
16. A postmarketing surveillance study of zopiclone in insomnia.
Mahendran R; Chee KT; Peh LH; Wong KE; Lim L
Singapore Med J; 1994 Aug; 35(4):390-3. PubMed ID: 7899899
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of a cognitive behavioral self-help program for patients with primary insomnia in general practice - a pilot study.
Katofsky I; Backhaus J; Junghanns K; Rumpf HJ; Hüppe M; von Eitzen U; Hohagen F
Sleep Med; 2012 May; 13(5):463-8. PubMed ID: 22342027
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
Scharf MB; Roth T; Vogel GW; Walsh JK
J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
20. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.
Jacobs GD; Pace-Schott EF; Stickgold R; Otto MW
Arch Intern Med; 2004 Sep; 164(17):1888-96. PubMed ID: 15451764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
